Relmada Therapeutics, Inc. (RLMD)
7.02
-0.19
(-2.64%)
USD |
NASDAQ |
Apr 27, 16:00
7.02
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics EPS Diluted (TTM) : -1.470 for Dec. 31, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.684 |
| Theravance Biopharma, Inc. | 2.028 |
| Avalo Therapeutics, Inc. | -6.096 |
| AN2 Therapeutics, Inc. | -1.164 |
| ACADIA Pharmaceuticals, Inc. | 2.288 |